Health news and commentary gathered by MedPage Today staff
— Health news and commentary gathered by MedPage Today staff
July 14, 2026
• 3 min read
Note that some links may require registration or subscription.
A cohort study found that diabetes patients taking GLP-1 receptor agonists had a higher risk of anterior ischemic optic neuropathy, a potentially blinding eye condition, though absolute risks were still small. (Annals of Internal Medicine)
News and commentary from the world of gastroenterology and hepatology
GLP-1 receptor agonists were associated with a higher risk for eye complications vs. other diabetes medications, two studies…
Health news and commentary gathered by MedPage Today staff
News and commentary from the world of gastroenterology and hepatology
Data collected from a number of clinical trials found that despite recent “buzz,” there is no significant link between GLP-1…
Studies show that GLP-1 receptor agonists have significant potential for treating glaucoma, diabetic retinopathy and other eye…
